NANOG and breast cancer: In breast cancer, ALKBH5 is a direct target of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α and regulates breast cancer stem cell phenotype by downregulating the m6A modification on Nanog mRNA methylation [34].